Frontiers in Medical Technology is a prominent open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2019, this journal has established a significant foothold in interdisciplinary research, seamlessly integrating advancements in biomedical engineering, medical laboratory technology, and health professions. With impressive rankings, including Q2 in Biomedical Engineering and Q1 in multiple medical categories, it consistently ranks among the top journals in its field, boasting a commendable impact in the health professions domain (ranked #9 out of 78). The journal aims to disseminate innovative breakthroughs and facilitate collaboration across various specialties, making it essential reading for researchers, practitioners, and students keen on the latest developments in medical technology. Being an open-access publication since 2021, it ensures that cutting-edge research is readily available to a global audience, thus enhancing accessibility and fostering a knowledge-driven approach in medical sciences.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Welcome to the Erciyes Medical Journal, a distinguished publication from the Erciyes University School of Medicine that has been dedicated to advancing the field of medical science since its establishment. This Open Access journal, available in both print (ISSN: 2149-2247) and online (E-ISSN: 2149-2549), offers researchers unparalleled access to cutting-edge research and medical advancements. Following its transition to open access in 2018, the journal aims to democratize knowledge, allowing healthcare professionals, researchers, and students alike to engage with high-quality content that is both accessible and impactful. Although its coverage in databases such as Scopus has been discontinued since 2018, the Erciyes Medical Journal continues to foster scholarly dialogue and innovation in medicine, addressing critical health issues relevant to the global community. As a hub for knowledge exchange, this journal not only publishes original research articles but also encourages the submission of reviews, case studies, and clinical practice articles, thereby facilitating a comprehensive understanding of medical challenges and breakthroughs.

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

World of Medicine and Biology is a leading academic journal dedicated to advancing the frontiers of medical and biological sciences. Published by the Scientific Society of Anatomists, Histologists & Embryologists in Ukraine, this journal provides a collaborative platform for researchers, professionals, and students to disseminate original research, critical reviews, and insightful discussions on a wide array of topics in these dynamic fields. With the ISSN 2079-8334, the journal aspires to bridge the gap between theory and practice, focusing on innovative methodologies, latest findings, and the relevance of biology to human health. Although the journal operates under a traditional access model, it ensures comprehensive reach through various indexing services and databases, solidifying its importance in the realm of scientific inquiry. As the field continues to evolve with new discoveries and technologies, the World of Medicine and Biology remains committed to fostering academic excellence and supporting the global research community in their endeavors.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

Physical and Engineering Sciences in Medicine is an esteemed peer-reviewed journal published by SPRINGER, dedicated to advancing the interdisciplinary fields of biomedical engineering and biophysics. With an ISSN of 2662-4729 and an E-ISSN of 2662-4737, this journal has carved a niche for itself since its inception in 2020. Situated in the Netherlands, it serves as a global platform for innovative research and developments that bridge the physical sciences and engineering with medical applications. The journal boasts a commendable range of quartile categorizations, highlighting its impact in various sectors including Instrumentation (Q1), Radiology (Q2), and Biotechnology (Q2). Its Scopus rankings further emphasize its relevance and quality, placing it in the top 15% in several categories. Being an Open Access title, it promotes the dissemination of knowledge, ensuring that vital research is accessible to all, thereby fostering collaboration among researchers, professionals, and students alike. The journal's objectives include promoting cutting-edge research, enhancing biomedical technology, and addressing complex health challenges through innovative engineering solutions, establishing it as a vital resource in the scientific community.

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.